News by Tag: Russian Pharma Industry
Russian Pharmaceutical Sector Exhibiting Strong Performance
February 9, 2012
Backed by government support and private sector investment, the Russian pharmaceutical market is likely to grow at a CAGR of 13% during 2011-2013, says RNCOS.
February 9, 2012
Backed by government support and private sector investment, the Russian pharmaceutical market is likely to grow at a CAGR of 13% during 2011-2013, says RNCOS.
Diabetes Prevalence in Russia Sets Insulin on Growth Trajectory
August 30, 2011
The number of diabetes patients has been consistently increasing in Russia due to rapid adoption of modern ways of living, says RNCOS in its latest research study.
August 30, 2011
The number of diabetes patients has been consistently increasing in Russia due to rapid adoption of modern ways of living, says RNCOS in its latest research study.
Government Intervention to Ensure Russian Pharma Market Growth
July 25, 2011
The increasing role of the Government evident from the numerous initiatives taken by them will ensure that the Russian pharma market continue on its tremendous growth trajectory in the coming future, says RNCOS.
July 25, 2011
The increasing role of the Government evident from the numerous initiatives taken by them will ensure that the Russian pharma market continue on its tremendous growth trajectory in the coming future, says RNCOS.
Parapharmaceuticals to Boost the Russian Pharma Market
June 24, 2011
The Russian pharma market is expected to grow at a CAGR of 13% backed by the incredible growth of parapharmaceuticals segment, says RNCOS in its latest research offering.
June 24, 2011
The Russian pharma market is expected to grow at a CAGR of 13% backed by the incredible growth of parapharmaceuticals segment, says RNCOS in its latest research offering.
Russian Pharma Market Forecasted to Show Stupendous Growth
February 15, 2011
Rising healthcare concerns and active government participation will propel the Russian pharmaceutical industry to grow at a CAGR of 13% during 2011-2013, says RNCOS.
February 15, 2011
Rising healthcare concerns and active government participation will propel the Russian pharmaceutical industry to grow at a CAGR of 13% during 2011-2013, says RNCOS.